Literature DB >> 7043341

Intracervical application of prostaglandin gel for induction of term labor.

U Ulmsten, L Wingerup, P Belfrage, G Ekman, N Wiqvist.   

Abstract

A new gel for local application of prostaglandins has been elaborated. The new gel, based on a lyophilized prostaglandin E2 (PGE2) starch powder, seems to have solved most of the pharmaceutical and clinical problems associated with local administration of prostaglandins. In a randomized double-blind study, 50 nulliparous patients with an unfavorable cervical state at term were given 2 ml gel containing 0.5 mg PGE2 (PGE2 gel) or gel without PGE2 (placebo gel). The gel was deposited into the cervical canal. Among patients given PGE2 gel, 11 of 25 had induced labor, delivering without further stimulation within 24 hours. In patients given placebo gel, 2 of 25 were delivered with 24 hours. This difference is statistically significant (P less than .01). Patients undelivered after treatment with PGE2 gel achieved a considerable and statistically significant improvement of cervical score, whereas in patients in whom labor was not induced successfully by placebo gel treatment no significant changes in cervical score were registered. In a subsequent open study another 70 term patients of varied parity were given 0.5 mg PGE2 gel. Thirty-eight patients (54%) had successfully induced labor. Among the remaining undelivered patients, considerable ripening of the cervix occurred. Thus, the cervical score changed from a mean of 3.2 prior to treatment to a mean of 6.5 by 24 hours after treatment. Gastrointestinal discomforts were not observed. Signs of uterine hyperstimulation were registered in 1 patient.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7043341

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

Review 1.  Chemotherapeutic induction of labour. A rational approach.

Authors:  E M Xenakis; J M Piper
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

2.  Hypoxia and PGE(2) regulate MiTF-CX during cervical ripening.

Authors:  Annavarapu Hari Kishore; Xiang-Hong Li; R Ann Word
Journal:  Mol Endocrinol       Date:  2012-11-08

3.  Proteoglycan metabolism in the connective tissue of pregnant and non-pregnant human cervix. An in vitro study.

Authors:  M Norman; G Ekman; U Ulmsten; K Barchan; A Malmström
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

Review 4.  Use of labour induction and risk of cesarean delivery: a systematic review and meta-analysis.

Authors:  Ekaterina Mishanina; Ewelina Rogozinska; Tej Thatthi; Rehan Uddin-Khan; Khalid S Khan; Catherine Meads
Journal:  CMAJ       Date:  2014-04-28       Impact factor: 8.262

5.  Prevention of cesarean section. Does intracervical dinoprostone work?

Authors:  G J Gilson; L A Izquierdo; M S Chatterjee; L B Curet; C R Qualls
Journal:  West J Med       Date:  1993-08

6.  Fetal circulation 60 to 80 minutes after vaginal prostaglandin E2 in pregnant women at term.

Authors:  A Lindblad; G Ekman; K Marsál; U Ulmsten
Journal:  Arch Gynecol       Date:  1985

7.  Intracervical application of PGE2-gel combined with early intravenous infusion of oxytocin for induction of term labor in women with unripe cervix.

Authors:  G Ekman; U Ulmsten; L Wingerup
Journal:  Arch Gynecol       Date:  1983

8.  Intracervical versus intravaginal PGE2 for induction of labor at term in patients with an unfavorable cervix.

Authors:  U Ulmsten; G Ekman; P Belfrage; M Bygdeman; C Nyberg
Journal:  Arch Gynecol       Date:  1985

9.  Experience with an industrially manufactured gel PGE2 for cervical priming.

Authors:  J Floberg; J Allen; P Belfrage; M Bygdeman; U Ulmsten
Journal:  Arch Gynecol       Date:  1983

10.  Maternal Whole Blood Gene Expression at 18 and 28 Weeks of Gestation Associated with Spontaneous Preterm Birth in Asymptomatic Women.

Authors:  Yujing J Heng; Craig E Pennell; Sheila W McDonald; Angela E Vinturache; Jingxiong Xu; Mary W F Lee; Laurent Briollais; Andrew W Lyon; Donna M Slater; Alan D Bocking; Lawrence de Koning; David M Olson; Siobhan M Dolan; Suzanne C Tough; Stephen J Lye
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.